Facebook Linkedin Twitter
Home Topics Molecular Dx Page 261

Molecular Dx

Elements of Change—How Molecular Diagnostics and Histology Will Deliver Growth to U.S. IVD Market
Molecular Dx

Elements of Change—How Molecular Diagnostics and Histology Will Deliver Growth to U.S. IVD Market

Emil Salazar
0
The point-of-care testing market can expect significant growth
Molecular Dx

Point-of-Care Reaches a Crossroads

Alex Philippidis
0
The growth of genomic medicine has cast a spotlight on the need for higher-resolution technologies for chromosomal analysis. [© fotohunter/iStock]
Molecular Dx

Cytogenomic Analyses for Genetic Disease Detection and Diagnosis

Patricia Fitzpatrick Dimond, Ph.D.
0
Each year millions of babies are routinely screened for certain genetic
Molecular Dx

The Public Health Role in Translating Advances in Genomics

Muin J. Khoury, M.D., Ph.D. and Scott Bowen
0
Exome sequencing has promise in oncology testing
Molecular Dx

NGS Ready for Clinical Oncology Testing

Kate Marusina, Ph.D.
0
The CVD space is an attractive segment wherein POC diagnostics finds significant utility. [© Alexander Raths - Fotolia.com]
Molecular Dx

POC Diagnostics in the Cardiovascular Disease Space

Enal Razvi, Ph.D. and Gary M. Oosta, Ph.D.
0
Source: ©.shock—Fotolia.com
Molecular Dx

FDA to Require Premarketing Approval for “High-Risk” LDTs

Alex Philippidis
0
Source: © Elena Kovaleva - Fotolia.com
Molecular Dx

Berry Genomics and Illumina Partner on NGS System for Chinese Clinics

0
Source: © FotolEdhar - Fotolia.com
Molecular Dx

Beckman Coulter to Acquire Clinical Microbiology Business from Siemens

0
To increase the chances of being successful
Molecular Dx

Clinical Laboratory, Meet Molecular Diagnostics

Alex Philippidis
0
1...260261262...265Page 261 of 265

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine